LATEST ALERTS
CannIntelligence reviews developments in cannabis regulation in Latin America in 2022 and looks forward to likely further opening-up of the industry in many of the region’s nations in 2023
This report provides a detailed overview of Australia’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It’s possible
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
The FDA has made clear for years that CBD in food is illegal in the US, as it violates the Federal Food, Drug, and Cosmetic (FD&C) Act. What’s different this time?
This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids, with concerns around CBD increasing even as many countries make moves towards the legalisation of cannabis
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids
A 2021 acquisition deal between two cannabis companies over a lucrative shopfront in Orange County, California, has resulted in both companies filing legal claims against each other
The United Nations may be growing more accepting of a global legal cannabinoid sector, but it does not believe many countries have the capacity to successfully regulate such markets
The sale and possession of CBD will be banned in Hong Kong from the beginning of February 2023 following an announcement earlier this year. Under the new rules, CBD will be classified in the same way as heroin and cocaine
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis, covering all policy areas
Canadian advocates for therapeutic access to psilocybin are ramping up their efforts to get the federal government to grant exemptions to the country’s drug laws so patients and healthcare providers can legally access the drug
This snapshot of Germany’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
This snapshot of Spain’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
The Medical Marijuana and Cannabidiol Research Expansion Act, aimed at increasing research into the medical benefits of cannabis, has been signed into law by US president Joe Biden
The South Korean legislation does not make a clear distinction between hemp and cannabis. This report provides a detailed overview of the regulatory framework in place for hemp, cannabinoids and cannabis, covering all policy areas
This snapshot of the Netherland’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
This snapshot of France’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Members of the Mexican cannabis sector have told CannIntelligence they are pessimistic about whether the framework to regulate the national medical cannabis industry will be implemented before 2024
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
